ATTO / EXCLUDED
Attovia Therapeutics, Inc.
GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P.
Other; Other; Other; Other; Other; Other; Other; Other
Common Stock · Transaction 2026-08-06 · Filed 2026-08-28
Original SEC filing · Accession 0000886982-26-000522 · Row 9058058
Reported transaction details
- Shares transacted
- 1,957,134.0
- Security / share class
- Common Stock
- Reported ownership
- Indirect — see ownership footnotes
- Reported price per share
- 0.0
- Transaction value (shares × reported price)
- 0
Uses reconciled original-filing precision. Value is derived and may be approximate when the filing reports rounded or averaged prices. Currency has not been independently verified. These are reported transaction amounts, not adjusted market prices used for returns.
Historical purchase-size comparison is not yet available. The pilot does not establish this insider’s usual purchase size.
Excluded: not a qualifying purchase
The current analysis covers qualifying purchases of U.S.-listed ordinary/common shares and excludes funds and preferred shares.
Returns were not calculated for this transaction. This does not mean zero performance or missing price data. The reported amounts and original filing remain available for reference.
Assessment
Recorded assessment reasons
- amendment review
- not purchase acquisition
- no executive or director
- joint owner review
- nonpositive or missing amount review
- historical security identity unverified
Original filing: reconciled. Security: review.
Reported bulk amounts: 1957134.0 shares × 0.0 per share.
Referenced filing footnotes
The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.
All shares of the Issuer's redeemable convertible preferred stock automatically converted into shares of the Issuer's common stock on a 1-for-1 basis, adjusted for a 1-for-9.29 reverse stock split effected by the Issuer on July 29, 2026, upon the completion of the Issuer's initial public offering (the "IPO").
This statement is being filed by Goldman Sachs Group, Inc. ("GS Group"), GS&Co, Goldman Sachs Asset Management, L.P. ("GSAM LP"), Broad Street Principal Investments L.L.C. ("BSPI"), which directly holds 96,190 shares of common stock purchased in the IPO and 468,565 shares of common stock converted from 3,497,806 shares of Series B Preferred Stock and 855,179 shares of Series C Preferred Stock, WSLS Offshore Investments, SLP ("WSLS Offshore"), which directly holds 131,283 shares of common stock purchased in the IPO and 639,518 shares of common stock converted from 4,773,948 shares of Series B Preferred Stock and 1,167,182 shares of Series C Preferred Stock, West Street Life Sciences I, L.P. ("WSLS I"), which directly holds 137,708 shares of common stock purchased in the IPO and 670,812 shares of common stock converted from 5,007,564 shares of Series B Preferred Stock and 1,224,299 shares of Series C Preferred Stock,... (continued in footnote 7)
GS&Co's transactions in or with respect to the Issuer's common stock on August 5, 2026 consisted of purchases of a total of 85,000 shares, sales of a total of 105,807 shares, and establishment of long equity swap positions with respect to a total of 105,807 shares. The equity swap positions were inadvertently omitted from the Reporting Persons' original Form 4.
(continued from footnote 6)...WSLS Emp Offshore Investments, L.P. ("WSLS Emp Offshore"), which directly holds 36,927 shares of common stock purchased in the IPO and 179,879 shares of common stock converted from 1,342,794 shares of Series B Preferred Stock and 328,300 shares of Series C Preferred Stock, and WSLS Emp Onshore Investments, L.P. ("WSLS Emp Onshore"), which directly holds 97,892 shares of common stock purchased in the IPO and 476,858 shares of common stock converted from 3,559,718 shares of Series B Preferred Stock and 870,315 shares of Series C Preferred Stock. GS&Co is a direct subsidiary of GS Group and is the manager of BSPI. WSLS Offshore, WSLS I, WSLS Emp Offshore, and WSLS Emp Onshore are investment vehicles managed by GSAM LP, an indirect subsidiary of GS Group.
Method and limitations
Daily-close v1: split-adjusted SIP daily bars supply purchase-date closes and all exit closes for both stock and SPY. Disclosure entries use each symbol's first regular-session minute open strictly after SEC acceptance + five minutes; acceptance is a publication proxy. Entry is session zero; exits occur at i+h. Daily bars are used only after the New York calendar day has ended, with a 15-minute data delay. Prices are vendor aggregates, not guaranteed fills or universally identical to official auction prices. Excludes dividends, fees and slippage. Related transaction rows are not independent signals.
Run cutoff: 2026-11-04T12:55:26.004Z. SEC acceptance: 2026-08-28T21:38:09.000Z.
Discretionary intent remains uncertain unless supported by the filing. Unresolved amendments and security identities are not silently treated as eligible trades.